Sunday, January 20, 2008

Biotechnology Helps To Cure Autism In Mice.

Researchers at MIT’s Picower institute for learning and memory have reversed almost all symptoms of fragile x syndrome in a mouse model for the disease. In human beings and in mice, fragile x syndrome is the common inherited cause of mental retardation and autism.

The researchers found that a 50 percent reduction in the production of mGluR5 eased the fragile X syndrome’s symptoms such as seizures and problems related to the eye, nerves, brain, memory and body growth.

This research holds great hope for the treatment of autism in human beings.
The National Institute of Science and Media keeps account of the recent breakthroughs in the world of science.

The National Institute of Science and Media publishes various books on biotechnology and life sciences written by eminent researchers like Joel Ball.

No comments: